The non-receptor tyrosine kinase ACK: regulatory mechanisms, signalling pathways and opportunities for attACKing cancer
Author:
Affiliation:
1. Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
2. Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, U.K.
Abstract
Publisher
Portland Press Ltd.
Subject
Biochemistry
Link
https://portlandpress.com/biochemsoctrans/article-pdf/47/6/1715/864506/bst-2019-0176c.pdf
Reference92 articles.
1. Cloning and characterization of a novel Cdc42-associated tyrosine kinase, ACK-2, from bovine brain;J. Biol. Chem.,1997
2. Kos1, a nonreceptor tyrosine kinase that suppresses Ras signaling;Oncogene,2003
3. Activated Cdc42 kinase regulates Dock localization in male germ cells during drosophila spermatogenesis;Dev. Biol.,2013
4. ACK family tyrosine kinase activity is a component of Dcdc42 signaling during dorsal closure in Drosophila melanogaster;Mol. Cell. Biol.,2002
5. Drosophila activated Cdc42 kinase has an anti-apoptotic function;Plos Genet.,2012
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance;Cancers;2024-08-02
2. Design, Synthesis, and Biological Evaluation of Dual Inhibitors of EGFRL858R/T790M/ACK1 to Overcome Osimertinib Resistance in Nonsmall Cell Lung Cancers;Journal of Medicinal Chemistry;2024-02-07
3. ISWM: an information security system for water surface oil spill monitoring based on NB-IoT;International Journal of Computational Science and Engineering;2024
4. Research Progress on AKC1 and Its Small Molecule Inhibitors in Tumor Occurrence and Development;Advances in Clinical Medicine;2024
5. Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer;Frontiers in Pharmacology;2023-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3